Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rein Therapeutics (RNTX) Preferred Dividend Payments (2016 - 2017)

Rein Therapeutics (RNTX) has disclosed Preferred Dividend Payments for 2 consecutive years, with $21000.0 as the latest value for Q2 2017.

  • On a quarterly basis, Preferred Dividend Payments rose 10.53% to $21000.0 in Q2 2017 year-over-year; TTM through Dec 2017 was $41000.0, a 45.33% decrease, with the full-year FY2017 number at $41000.0, up 115.79% from a year prior.
  • Preferred Dividend Payments was $21000.0 for Q2 2017 at Rein Therapeutics, up from $20000.0 in the prior quarter.
  • In the past five years, Preferred Dividend Payments ranged from a high of $21000.0 in Q2 2017 to a low of $18000.0 in Q1 2016.